Jennifer L Taubert
CIK 1745938 · EVP, WWC. Innovative Medicine · last filed 2026-08-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$56.55M
Companies
3
Total Filings
40
Lifetime Open-Market Net
-$36.87M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JNJ | EVP, WWC. Innovative Medicine | 209,451 | $270.00 | $56.55M | -$17.55M | 12 | 2026-08-18 |
| MCD | Director | — | $266.93 | — | $0 | 14 | 2026-07-02 |
| JOHNSON & JOHNSON (JNJ.WD) Delisted | EVP, WWC. Innovative Medicine | 194,451 | — | — | -$19.32M | 11 | 2026-02-18 |
Recent Filings · Page 4 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | MCD | Grant (A) | — | $0 | EDGAR |
| 2022-11-23 | JNJ | Mixed | — | -$8.02M | EDGAR |
| 2022-02-17 | JNJ | Mixed | +9,223 | -$1.47M | EDGAR |
| 2022-02-15 | JNJ | Mixed | +2,107 | -$200.9K | EDGAR |
| 2021-02-17 | JNJ | Mixed | +7,541 | -$1.00M | EDGAR |
| 2021-02-10 | JNJ | Grant (A) | — | $0 | EDGAR |
| 2020-02-18 | JNJ | Mixed | +7,856 | -$1.24M | EDGAR |
| 2020-02-12 | JNJ | Grant (A) | — | $0 | EDGAR |
| 2020-02-04 | JNJ | Mixed | +24,591 | -$3.54M | EDGAR |
| 2019-02-12 | JNJ | Mixed | +10,075 | -$1.29M | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.